LARGE FAMILY FOR LARGE ACHIEVEMENTS
We develop modern prevention, diagnostics and therapy products for health preservation and improved quality of life.
Press centre
NOTICE
NOTICE ON CONVENING AN EXTRAORDINARY SESSION OF THE GENERAL ASSEMBLY OF BOSNALIJEK D.D.
In accordance with the provisions of Article 45 (3), Article 46 (2) (3) and (5), Article 47 and Article 48 (1) of the current Statute of Bosnalijek d.d. (consolidated text, no. 2830/2017 of 18.09.2017), Article 230 (1) and Article 232 (3) of the Law on Companies (Official Gazette of FBiH, no. 81/15 and 75/2) and pursuant to the Supervisory Board Decision no. 3/22 of 06.01.2022, the following is hereby published:
MORE
PRESS CENTRE / NEWS
Bosnalijek Opens New Facility for Manufacturing Liquid and Semisolid Pharmaceutical Forms
With investment valued at 50 million convertible marks (BAM), Bosnalijek will see fivefold increase in its production capacities. This modern production plant ensures the reputation of a manufacturer with the highest quality standards.
In detail
PRESS CENTRE / NEWS
Two Bosnalijek Teams Won Valuable Prizes at Dolorex B2B Night Relay Race
Dolorex B2B night relay race, under a general sponsorship of Bosnalijek company, and Vienna Run4Lifestyle 10K Night Run, an international and socially responsible race, which opened the biggest festival of running in BiH “Olimpija Run Fest“, were held on Friday, 14 June 2019, in Sarajevo city center.
In detail
Useful Resources
januar 19. 2022 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%